TDM-guided Crushed Sofosbuvir-velpatasvir Treatment: A case study - Archive ouverte HAL Access content directly
Journal Articles Therapeutic Drug Monitoring Year : 2020

TDM-guided Crushed Sofosbuvir-velpatasvir Treatment: A case study

(1, 2, 3) , (1) , (1, 2, 3) , (3, 2) , (1) , (1) , (2, 1) , (1, 2, 3)
1
2
3

Abstract

In this study, the authors report the case of a patient diagnosed with hepatitis C virus who was treated with sofosbuvir-velpatasvir (400/100 mg). As the patient was unable to swallow whole tablets, therapeutic drug monitoring was performed to evaluate the effect of crushing sofosbuvir-velpatasvir tablets on drug absorption and global exposure.
Fichier principal
Vignette du fichier
Lalanne et al-2019-TDM-guided Crushed Sofosbuvir-velpatasvir Treatment.pdf (257.09 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-02440785 , version 1 (12-02-2020)

Identifiers

Cite

Sébastien Lalanne, Caroline Jezequel, Camille Tron, Marie-Clémence Verdier, Marion Mercerolle, et al.. TDM-guided Crushed Sofosbuvir-velpatasvir Treatment: A case study. Therapeutic Drug Monitoring, 2020, 42 (2), pp.163-164. ⟨10.1097/FTD.0000000000000718⟩. ⟨hal-02440785⟩
38 View
183 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More